Experience

Kynexis
• Biotechnology Research
• 1 - 100 Employee
• Chief Development Officer (CDO)

  • Jan 2023 - Present

Molecure
• Pharmaceutical Manufacturing
• Member Of The Supervisory Board

  • Jan 2022 - Present


Why2What

• India
• Technology, Information and Internet

• Passion for R&D in Lifesciences & Healthcare, consultant

  • Oct 2021 - Present

  I’m excited to share with you my career switch into consultancy. I created my own company called "Why2What". The reason for this name is very simple: always ask the "Why-question” first - building your strategy - before moving into the "What" – laying out the actions to achieve your end goal. I will be focussing on providing advice on strategy and implementation in early stage development programs and innovation in life sciences and healthcare. I want to use my experience to move… Show more I’m excited to share with you my career switch into consultancy. I created my own company called "Why2What". The reason for this name is very simple: always ask the "Why-question” first - building your strategy - before moving into the "What" – laying out the actions to achieve your end goal. I will be focussing on providing advice on strategy and implementation in early stage development programs and innovation in life sciences and healthcare. I want to use my experience to move projects forward on their development path: the cross-functional expertise in project teams is key to success and requires clear direction and strong leadership in their support. For more than 25 years, I've been building up diverse experiences in drug development within global pharma. At Galapagos, I was responsible for strategy and early development projects, including the cystic fibrosis program and various highly innovative assets in the immune-inflammation space. At UCB, I worked as project leader and took responsibility for identifying and assessing innovative solutions-beyond-the-pill with external partners/start-ups and academics. At JNJ, I was exposed to both early and late stage development as clinical pharm leader, project leader and functional line manager. I contributed to multiple drug registration files and to development programs across different therapeutic areas. My passion lies in turning great innovative ideas into impact and value, looking forward to collaborating with you in the future. Nancy Van Osselaer Why2What Passion for R&D in Life Sciences and Healthcare Show less I’m excited to share with you my career switch into consultancy. I created my own company called "Why2What". The reason for this name is very simple: always ask the "Why-question” first - building your strategy - before moving into the "What" – laying out the actions to achieve your end goal. I will be focussing on providing advice on strategy and implementation in early stage development programs and innovation in life sciences and healthcare. I want to use my experience to move… Show more I’m excited to share with you my career switch into consultancy. I created my own company called "Why2What". The reason for this name is very simple: always ask the "Why-question” first - building your strategy - before moving into the "What" – laying out the actions to achieve your end goal. I will be focussing on providing advice on strategy and implementation in early stage development programs and innovation in life sciences and healthcare. I want to use my experience to move projects forward on their development path: the cross-functional expertise in project teams is key to success and requires clear direction and strong leadership in their support. For more than 25 years, I've been building up diverse experiences in drug development within global pharma. At Galapagos, I was responsible for strategy and early development projects, including the cystic fibrosis program and various highly innovative assets in the immune-inflammation space. At UCB, I worked as project leader and took responsibility for identifying and assessing innovative solutions-beyond-the-pill with external partners/start-ups and academics. At JNJ, I was exposed to both early and late stage development as clinical pharm leader, project leader and functional line manager. I contributed to multiple drug registration files and to development programs across different therapeutic areas. My passion lies in turning great innovative ideas into impact and value, looking forward to collaborating with you in the future. Nancy Van Osselaer Why2What Passion for R&D in Life Sciences and Healthcare Show less


2 Bridge
• Belgium
• Business Consulting and Services
• 1 - 100 Employee
• VP Early development and Innovation

  • Nov 2021 - Oct 2023


Galapagos

• Spain
• Design Services

• Head of Early Development Project Leaders

  • Dec 2020 - Nov 2021

• Project Leader Development

  • May 2017 - Nov 2020



UCB

• Apparel & Fashion
• 1 - 100 Employee

• Head of Innovative Solutions and Assessments, Neurology New Patient Solutions

  • Jan 2015 - Apr 2017

  Identify and select innovative patient solutions beyond current treatment in neurology

• Mission Head Towards better outcome for epilepsy patients

  • Apr 2013 - Dec 2014

  Identify patient solutions for better outcome of epilepsy patients beyond the pill, as part of the Vimpat Patient Solutions team

• Global Project Leader

  • Mar 2012 - Mar 2013



Johnson & Johnson

• Law Practice
• 1 - 100 Employee

• Compound Development Team Leader

  • 2008 - Feb 2012

• Site Director Clinical Pharmacokinetics

  • 2002 - Aug 2008